By Shawn Hauser, Partner
Mar 12, 2020
The FDA issued its first report to Congress, along with a public update regarding its progress in evaluating lawful pathways for the marketing of CBD products and considering a risk-based enforcement policy. Read the summary from VS Hemp Department leader, Shawn Hauser.
By Michelle Bodian
Mar 9, 2020
With any new consumer product craze, lawsuits will inevitably follow. The hemp-CBD industry is no exception. The current wave of CBD-related lawsuits has primarily been product liability claims.
By David Kramer, Senior Associate
Mar 3, 2020
California employers beware: as of January 1, 2020, it is increasingly likely that any person who performs services for your company will be classified as an employee. The reason for this seismic shift is Assembly Bill 5 (AB-5).
By Shawn Hauser, Partner
Feb 27, 2020
The beginning of federally regulated hemp has been marred by industry-wide concerns about an overly restrictive federal program, and what may come from the USDA review of more than 4,600 comments to its interim final rule governing U.S. hemp production.
By Elliot Choi, Counsel; Jennifer Cabrera, Counsel
Feb 20, 2020
In January 2020, New York Governor Andrew Cuomo released a draft budget that included a proposal for adult-use cannabis legalization for the Empire State.
Commentary and analysis on cannabis, hemp, psychedelics, and other emerging therapies from the attorneys and policy specialists at the nation’s leading cannabis law firm.